[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631767":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":35,"collaborators":39,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Ludwig-Maximilians - University of Munich","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"prospective cohort study",null,"The study cohort for the DARE project includes customers and patients from pharmacies located in both urban and rural areas. These participants represent a diverse population segment, including individuals who might not regularly access traditional healthcare services, particularly in rural regions where medical facilities are less accessible.\n\nCohort Details:\n\n1. Eligibility Criteria:\n\n   * Age: 60 years and older.\n   * Cognitive impairments noted by participants themselves, relatives, or pharmacy staff.\n   * Sufficient understanding of the German language.\n2. Inclusion Focus:\n\n   * Individuals with early cognitive symptoms or mild dementia.\n   * Those potentially underserved by conventional healthcare systems, such as isolated or single individuals.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Carolin I Kurz, M.D.","CONTACT","+498944005863","psy.alzheimerzentrum@med.uni-muenchen.de",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Department of Psychiatry and Psychotherapy, LMU Hospital","RECRUITING","Munich","Bavaria","80336","Germany","DE",{"type":28,"coordinates":29},"Point",[30,31],11.57549,48.13743,{"lat":31,"lon":30},[34],{"name":14,"role":15,"phone":10,"phoneExt":10,"email":17},{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Carolin Kurz","Dr. med. Carolin Kurz",[40],{"name":41,"class":42},"Bayerisches Staatsministerium für Gesundheit, Pflege und Prävention","UNKNOWN","100631767","dementia-friendly-apothecaries-as-a-resource-for-mental-heath-in-the-elderly-100631767",false,"NCT07504965","Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly","Demenz-freundliche Apotheken Als Ressource für Psychische Gesundheit im Alter","DARE","Inclusion Criteria\n\n1. Age: Participants must be 60 years or older at the time of consent.\n2. Language Proficiency: Sufficient knowledge of the German language to understand instructions and participate in the study.\n3. Cognitive Status: Presence of self-reported, relative-reported, or pharmacist-identified cognitive impairments (e.g., memory problems or mild cognitive changes).\n4. Consent: Ability to provide informed consent voluntarily.\n\nExclusion Criteria\n\n1. Severe Sensory Impairments: Participants unable to see or hear well enough to complete the digital assessments or questionnaires.\n2. Previous Dementia Diagnosis: Individuals with a prior formal diagnosis of dementia, whether with or without underlying pathology.\n3. Severe Cognitive or Physical Impairments: Any condition that would prevent meaningful participation in the digital tests or structured screening process.\n\nThese criteria aim to ensure that the study includes participants at risk of early cognitive decline while excluding those for whom the interventions or assessments would not be feasible or relevant.",true,"ALL","60 Years","90 Years",{"count":56,"type":57},1020,"ESTIMATED","OBSERVATIONAL","The DARE study (Dementia-Friendly Apothecaries as a Resource for Mental Health in the Elderly) is a multicenter, prospective cohort study aiming to identify individuals with cognitive impairments early in pharmacies and enhance their access to support services. Partner pharmacies are equipped with memory test stations, and pharmaceutical staff are trained to guide participants. The digital memory test evaluates cognitive, psychosocial, and health factors, displaying results in a traffic light graphic. Participants with concerning results are referred to specialists or support services.\n\nThe study's primary goals are to establish pharmacies as dementia screening hubs, improve care for affected individuals, promote interdisciplinary collaboration, and lay the groundwork for legal and billing frameworks. An optional subproject validates the screening through neurological evaluations.",[61,62],"Mild Cognitive Impairment","Mild Dementia",[64,65,66,67,68,69],"Dementia-friendly pharmacies","Cognitive impairment","Early detection","Accessible healthcare","Digital cognitive assessments","Prevention of dementia","2026-03-26",{"date":72,"type":73},"2026-04-01","ACTUAL",{"date":75,"type":73},"2025-07-01",{"date":77,"type":57},"2027-07-31",{"name":5,"class":6},1]